Publication search results
Page 1 of 50
How the latest NICE methods consultation could impact your evidence generation strategy
How the latest NICE methods consultation could impact your evidence generation strategy Authors: Lee D and Birnie R Publication type: White paper Citation: Lee D and Birnie R. How the latest NICE methods consultation could impact your evidence generation strategy. White Paper. 2020. Available at: https://www.bresmed.com/wp-11-20-how-the-latest-nice-methods-consultation-could-impact-your-evidence-generation-strategy/. Link to publication ⟶ ⟵ Back to Search Results
Uncategorised
27th November 2020
Did the NICE technical engagement process deliver more efficient decision making?
Did the NICE technical engagement process deliver more efficient decision making? Authors: Barnes A, Qu T, Kidd R, Taylor S, Lilley C and Lee D. Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR Europe 2020 Citation: Barnes A, Qu T, Kidd R, Taylor S, Lilley C and Lee D. Did the NICE technical […]
Uncategorised
16th November 2020
Context matters – a taxonomy of real-world data and evidence to support HTA decision-making
Context matters – a taxonomy of real-world data and evidence to support HTA decision-making Authors: Murphy L, Mestre Ferrandiz J, Solà-Morales O, de Pouvourville G, Cunningham D, Corry S and Akehurst R. Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR Europe 2020 Citation: Murphy L, Mestre Ferrandiz J, Solà-Morales O, de Pouvourville G, […]
Uncategorised
Matching-adjusted indirect treatment comparisons of the effect of lorlatinib versus chemotherapy on overall survival and progression-free survival for patients with second-line or later anaplastic lymphoma kinase-positive advanced non-small cell lung cancer
Matching-adjusted indirect treatment comparisons of the effect of lorlatinib versus chemotherapy on overall survival and progression-free survival for patients with second-line or later anaplastic lymphoma kinase-positive advanced non-small cell lung cancer Authors: Smith S, Albuquerque de Almeida F, Inês M, Iadeluca L and Cooper M. Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR […]
Uncategorised
A review of consistencies in decision-making across NICE health technology assessments of immune heckpoint inhibitors
A review of consistencies in decision-making across NICE health technology assessments of immune heckpoint inhibitors Authors: Hale O, Casson J, Horscroft J, Sullivan W and Kiff C. Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR Europe 2020 Citation: Hale O, Casson J, Horscroft J, Sullivan W and Kiff C. A review of consistencies […]
Uncategorised
Cost-effectiveness analysis of NOVEL therapies for HER2+ metastatic breast cancer- [FAM-] trastuzumab deruxtecan versus tucatinib trastuzumab and capecitabine
Cost-effectiveness analysis of NOVEL therapies for HER2+ metastatic breast cancer- [FAM-] trastuzumab deruxtecan versus tucatinib trastuzumab and capecitabine Authors: Vondeling G, Palaka E, Livings C, Naik J and Sullivan W Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR Europe 2020 Citation: Vondeling G, Palaka E, Livings C, Naik J and Sullivan W. Cost-effectiveness […]
Uncategorised
Cost-effectiveness analysis of lorlatinib in patients previously treated with anaplastic lymphoma kinase inhibitors for non-small cell lung cancer in Greece
Cost-effectiveness analysis of lorlatinib in patients previously treated with anaplastic lymphoma kinase inhibitors for non-small cell lung cancer in Greece Authors: Gourzoulidis G, Zisimopoulou O, Boubouchairopoulou N, Michailidi C, Lowry C, Tzanetakos C and Kourlaba G. Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR Europe 2020 Citation: Gourzoulidis G, Zisimopoulou O, Boubouchairopoulou N, […]
Uncategorised
An incremental effectiveness analysis of lorlatinib for the treatment of ALK-positive advanced non-small cell lung cancer that has progressed after another ALK tyrosine kinase inhibitor in Portugal
An incremental effectiveness analysis of lorlatinib for the treatment of ALK-positive advanced non-small cell lung cancer that has progressed after another ALK tyrosine kinase inhibitor in Portugal Authors: Guerreiro R, Paquete A, Iadeluca L, Almond C, Albuquerque de Almeida F, Inês M, Costa J, Borges M and Silva Miguel L Publication type: Conference Proceedings – […]
Uncategorised
‘Excel cannot complete this task’: Drawing parallels between UK Test and Trace and health economic models
‘Excel cannot complete this task’: Drawing parallels between UK Test and Trace and health economic models Authors: Lee D, Hart R, Burns D, Gregory J, Horgan J Publication type: White paper Citation: Lee D, Hart R, Burns D, Gregory J, Horgan J. ‘Excel cannot complete this task’: Drawing parallels between UK Test and Trace and […]
Uncategorised
30th October 2020
Page 1 of 50
